Preventing further development of antibiotic resistance in pneumococcal isolates in Northwest Russia


October 2020 -
September 2021
4. EUSBSR support 4.1 Seed Money

AMR_Northwest_Russia

The project AMR_Northwest_Russia addresses the challenge of regional healthcare authorities and local healthcare institutions to treat patients exposed to developing a bacterial superinfection combined with a coronavirus infection (COVID-19). As the diagnostic and treatment of invasive pneumococcal disease (IPD) in the Northwest part of Russia is not optimal, the project aims to increase diagnostics quality and establish the monitoring system that can help to improve treatment quality for the region’s inhabitants.

Budgets

Total
€ 0.05
million
Erdf
€ 0.03
million
Eni + Russia
€ 0.01
million
Norway
€ 0.00
million

PARTNERS